CVS Health Corp (CVS)
Working capital turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 372,809,000 | 368,912,000 | 363,248,000 | 360,935,000 | 357,776,000 | 347,809,000 | 339,204,000 | 330,919,000 | 322,467,000 | 315,225,000 | 307,860,000 | 299,840,000 | 292,111,000 | 285,061,000 | 278,323,000 | 271,048,000 | 268,706,000 | 266,041,000 | 263,795,000 | 261,885,000 |
| Total current assets | US$ in thousands | 68,645,000 | 67,343,000 | 69,952,000 | 67,473,000 | 67,858,000 | 70,143,000 | 67,756,000 | 68,706,000 | 65,633,000 | 68,341,000 | 62,142,000 | 61,483,000 | 60,008,000 | 60,842,000 | 56,559,000 | 55,719,000 | 56,369,000 | 59,211,000 | 62,506,000 | 58,958,000 |
| Total current liabilities | US$ in thousands | 84,609,000 | 84,627,000 | 81,386,000 | 83,319,000 | 79,189,000 | 81,553,000 | 79,206,000 | 75,054,000 | 69,421,000 | 72,409,000 | 68,457,000 | 69,780,000 | 67,807,000 | 64,709,000 | 59,311,000 | 60,104,000 | 62,017,000 | 62,044,000 | 63,694,000 | 59,560,000 |
| Working capital turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $372,809,000K ÷ ($68,645,000K – $84,609,000K)
= —
The working capital turnover ratio for CVS Health Corp from March 31, 2020, to December 31, 2024, is not available in the provided data. This ratio indicates how efficiently the company is utilizing its working capital to generate sales revenue. Without the specific figures for working capital turnover, it is not possible to assess CVS Health Corp's ability to turn its working capital into sales within a given period. Relying solely on this ratio could limit a comprehensive analysis of the company's liquidity and operational efficiency.
Peer comparison
Dec 31, 2024